Evidence map›Paper›PMID 34370456›Full record

ArticleAnalytical chemistry2021

Synchrotron Radiation-Based Micro-XANES and Micro-XRF Study of Unsuccessfully Produced Egyptian Blue from the Late Hellenistic Production Site of Kos (Dodecanese, Greece).

Ariadne Kostomitsopoulou Marketou, Francesco Giannici, Søren Handberg, Wout de Nolf, Marine Cotte, Francesco Caruso

Abstract read
In one paragraph

Article in Analytical chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ariadne Kostomitsopoulou MarketouDepartment of Archaeology, Conservation and History, University of Oslo, Blindernveien 11, 0371 Oslo, Norway.ORCID 0000-0001-9416-6324
Francesco GianniciDipartimento di Fisica e Chimica, Università degli Studi di Palermo, Viale delle Scienze Ed. 17, 90128 Palermo, Italy.ORCID 0000-0003-3086-956X
Søren HandbergDepartment of Archaeology, Conservation and History, University of Oslo, Blindernveien 11, 0371 Oslo, Norway.
Wout de NolfEuropean Synchrotron Radiation Facility, BP-220, 38043 Cedex 9 Grenoble, France.
Marine CotteEuropean Synchrotron Radiation Facility, BP-220, 38043 Cedex 9 Grenoble, France.
Francesco CarusoDepartment of Archaeology, Conservation and History, University of Oslo, Blindernveien 11, 0371 Oslo, Norway.ORCID 0000-0002-0369-3194

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper examines the production technology of Egyptian blue, an ancient artificial pigment, through the investigation of an unsuccessfully produced pellet derived from the Hellenistic production site of Kos (Dodecanese, Greece). This heterogeneous material was investigated by a combination of laboratory and synchrotron radiation-based (SR) techniques: scanning electron microscopy coupled with energy-dispersive X-ray spectrometry, micro-Raman spectroscopy, high-resolution SR micro-X-ray fluorescence spectroscopy, and SR micro-X-ray absorption near-edge structure spectroscopy (XANES), at the ID21 beamline of the European Synchrotron Radiation Facility. Principal component analysis of a large dataset of 171 micro-XANES spectra acquired on the archaeological samples and on a series of reference copper compounds emphasizes high variations of XANES features due to different speciation and also orientation effects, as demonstrated by the simulated XANES spectra. The results indicate that, rather than inadequate firing temperatures that could have led to the reddish cuprite (Cu

Indexed as

CopperSynchrotronsGreeceSilicatesX-Ray Absorption SpectroscopyCoppercuprorivaiteSilicates

Identifiers

PMID34370456
PMCPMC8387973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.